Summaries of the Section H (HML) update

Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.

The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule. 

The changes will be published in the Online HML(external link) around the 23rd of this month and are effective from next month. 

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.

18 August 2026 - preview of changes for September 2026

Pharmaceutical

Change

Acitretin (Novatretin) cap 10 mg and cap 25 mg

price increase and addition of PSS

Amino acid formula powder 13.3 g protein, 57 g carbohydrate and 24.6 g fat per 100 g, can, 400 g (Alfamino) and powder 15 g protein, 56 g
carbohydrate and 20 g fat per 100 g, can, 400 g (Alfamino Junior)

price increase

Amino acid oral feed (Vivonex TEN) powder 11 g protein, 62 g carbohydrate and 1 g fat per sachet, 80 g sachet

price increase

Amlodipine (Vasorex) tab 2.5 mg, 5 mg and 10 mg

price increase and addition of PSS

Amoxicillin with clavulanic acid (Curam Duo 500/125) tab 500 mg with clavulanic acid 125 mg

price increase and addition of PSS

Anastrozole (Anatrole) tab 1 mg

price increase and addition of PSS

Atazanavir sulphate (Atazanavir Viatris) cap 150 mg and 200 mg 

new Pharmacode listing

  • Cap 150 mg (p’code 2736306)
  • Cap 200 mg (p’code 2736314)

Atropine sulphate (Atropt) eye drops 1%, 15 ml

price increase and addition of PSS

Betahistine dihydrochloride (Serc) tab 16 mg

price increase and addition of PSS

Betamethasone dipropionate (Diprosone) crm 0.05% and oint 0.05%, 50 g 

addition of PSS

Benzylpenicillin sodium [Penicillin G] (Sandoz) inj 600 mg (1 million units) vial 

price increase and addition of PSS

Bisoprolol fumarate (Ipca-Bisoprolol) tab 2.5 mg

addition of PSS

Bisoprolol fumarate (Ipca-Bisoprolol) tab 5 mg and 10 mg

price increase and addition of PSS

 

Bupivacaine hydrochloride inj 2.5 mg per ml, 20 ml ampoule sterile pack (Marcain) and inj 5 mg per ml, 4 ml ampoule (Marcain Isobaric)

price increase and addition of PSS

 

Calcitriol cap 0.25 mcg and 0.5 mcg

Brand change

Calcitriol Devatis – new listing and addition of PSS

  • Cap 0.25 mcg (p’code 2730537)
  • Cap 0.5 mcg (p’code 2730545)

Calcitriol XL and Calcitriol-AFT to be
delisted 1 February 2027

Calcium carbonate (Calci-Tab 500) tab 1.25 g (500 mg elemental)

price increase and addition of PSS

 

Captopril (DP-Captopril) oral liq 5 mg per ml, 100 ml

price increase and addition of PSS

 

Cefazolin (Cefazolin-AFT) inj 500 mg vial

price increase and addition of PSS

Cefazolin (Cefazolin-AFT) inj 1 g vial and 2 g vial

addition of PSS

Cetirizine hydrochloride (Histaclear) oral liq 1 mg per ml, 200 ml

price increase

Chlorhexidine with cetrimide (LumaCina) irrigation soln 0.05% with cetrimide 0.5%, 30 ml ampoule

new listing (p’code 2735040)

Clarithromycin (Klacid IV) inj 500 mg vial

price increase and addition of PSS

Clonidine (Mylan) patch 2.5 mg, 100 mcg per day, patch 5 mg, 200 mcg per day and patch 7.5 mg, 300 mcg per day

price increase and addition of PSS

Cyclizine lactate inj 50 mg per ml, 1 ml ampoule 

Brand change

  • Cyclizine lactate Medsurge – new listing and addition of PSS (p’code 2696290)
  • Hameln to be delisted 1 February 2027

Dapsone (Dapsone (Rising)) tab 25 mg

new listing (p’code 2736284)

Dexmedetomidine inj 100 mcg per ml, 2 ml
ampoule 

Brand change

  • Dexmedetomidine Medsurge – new listing and addition of PSS (p’code 2651017)
  • Dexmedetomidine Viatris to be
    delisted 1 April 2027

Docusate sodium (Coloxyl) tab 50 mg and 120 mg

price increase and addition of PSS

Donepezil hydrochloride (Ipca-Donepezil) tab 5 mg and 10 mg

price increase and addition of PSS

 

Droperidol (Droperidol Panpharma) inj 2.5 mg per ml, 1 ml ampoule

to be delisted 1 December 2026

 

Dulaglutide (Trulicity) inj 1.5 mg per 0.5 ml
prefilled pen

amended restriction criteria

 

Enoxaparin sodium

new Pharmacode listing

  • Inj 20 mg in 0.2 ml syringe
    (Clexane) (p’code 2732955)
  • Inj 40 mg in 0.4 ml syringe
    (Clexane) (p’code 2732963)
  • Inj 60 mg in 0.6 ml syringe
    (Clexane) (p’code 2732971
  • Inj 80 mg in 0.8 ml syringe
    (Clexane) (p’code 2732998)
  • Inj 100 mg in 1 ml syringe
    (Clexane) (p’code 2733005)
  • Inj 120 mg in 0.8 ml syringe
    (Clexane Forte) (p’code 2733013)
  • Inj 150 mg in 1 ml syringe
    (Clexane Forte) (p’code 2733021)

Escitalopram (Ipca-Escitalopram) tab 10 mg and 20 mg

price increase and addition of PSS

 

Fentanyl (Biomed) inj 10 mcg per ml, 100 ml bag

price increase and addition of PSS

Finasteride (Ricit) tab 5 mg

price increase and addition of PSS

Glucose [Dextrose] (Biomed) inj 50%, 10 ml
ampoule and inj 50%, 90 ml bottle 

price increase and addition of PSS

Indapamide (Dapa-Tabs) tab 2.5 mg

price increase and addition of PSS

Isosorbide mononitrate (Duride) tab long-acting 60 mg

price increase and addition of PSS

 

Haemophilus influenzae type B vaccine (Act-HIB) inj 10 mcg vial with diluent syringe

amended restriction criteria

High arginine oral feed 1.4 kcal/ml (Impact
Advanced Recovery) liquid 10.4 g protein, 8 g
carbohydrate, 4.4 g fat and 0 g fibre per 100 ml, 250 ml carton 

price increase

Hydrocortisone and paraffin liquid and lanolin (DP Lotn HC) lotn 1% with paraffin liquid 15.9% and lanolin 0.6%, 250 ml

price increase and addition of PSS

Hydroxyurea [hydroxycarbamide] (Devatis) cap 500 mg

price increase and addition of PSS

 

Hyoscine butylbromide (Spazmol) inj 20 mg, 1 ml ampoule

price increase and addition of PSS

Ketamine (Ketalar) inj 100 mg per ml, 2 ml vial

Pharmacode 436895 delisted 1 September 2026

Lamivudine

  • Tab 150 mg (Lamivudine Viatris)
  • Tab 100 mg (Zetlam)

price increase and addition of PSS

Lidocaine [lignocaine] hydrochloride with
adrenaline and tetracaine hydrochloride
(Laceraine) gel 4% with 0.18% adrenaline and 0.5% tetracaine, 4 ml vial

new listing (p’code 2736349)

Liraglutide (Victoza) inj 6 mg per ml, 3 ml prefilled pen

amended restriction criteria

Low electrolyte oral feed 2 kcal/ml (Novasource Renal (Vanilla)) liquid 9.1 g protein, 19 g
carbohydrate and 10 g fat per 100 ml, 200 ml
bottle

price increase

Low-GI oral feed 1 kcal/ml (Nutren Diabetes
(vanilla)) liquid 7 g protein, 10.9 g carbohydrate, 2.7 g fat and 2 g fibre per 100 ml, 200 ml bottle

price increase

Montelukast (Montelukast (Sandoz)) tab 4 mg

new listing (p’code 2735954)

Morphine sulphate (Biomed) inj 1 mg per ml, 100 ml bag, inj 1 mg per ml, 10 ml syringe and inj 1 mg per ml, 50 ml syringe

price increase and addition of PSS

Naltrexone hydrochloride (Naltrexone-GH) tab 50 mg

new listing (p’code 2692961)

Nystatin

  • Oral liquid 100,000 u per ml, 24 ml (Nilstat)
  • Vaginal crm 100,000 u per 5 g with
    applicator(s), 75 g (Nilstat)

price increase and addition of PSS

 

Olanzapine (APO-Olanzapine)

new listing

  • Tab 2.5 mg (p’code 2736152)
  • Tab 5 mg (p’code 2736160)
  • Tab 10 mg (p’code 2736179)

Oral feed (Sustagen Hospital Formula (Chocolate and Vanilla)) powder 23 g protein, 65 g
carbohydrate and 2.5 g fat per 100 g, can, 840 g

price increase

Paracetamol (Gacet) suppos 125 mg, 250 mg and 500 mg 

price increase and addition of PSS

Paraffin (EVARA White Soft Paraffin) white soft, 450 g

price decrease and addition of PSS

Perindopril

 

new listing

  • Tab 2.5 mg (Coversyl 2.5) (p’code 2726491)
  • Tab 5 mg (Coversyl 5) (p’code 2726505)
  • Tab 10 mg (Coversyl 10) (p’code 2726513)

Pine tar with trolamine laurilsulfate and fluorescein (Pinetarsol) soln 2.3% with trolamine laurilsulfate and fluorescein sodium, 500 ml

price increase and addition of PSS

 

Poloxamer (Coloxyl) oral drops 10%, 30 ml

price increase and addition of PSS

Potassium iodate (NeuroTabs) tab 253 mcg (150 mcg elemental iodine)

price increase and addition of PSS

 

Propranolol (Cardinol LA) cap long-acting 160 mg

to be delisted 1 January 2027

Protein supplement (Resource Beneprotein)
powder 6 g protein per 7 g, can, 227 g 

price increase

Remifentanil (Remifentanil-AFT) inj 1 mg vial and 2 mg vial

price increase and addition of PSS

 

Ropivacaine hydrochloride (Ropivacaine Kabi)

  • Inj 2 mg per ml, 10 ml ampoule
  • Inj 2 mg per ml, 20 ml ampoule
  • Inj 2 mg per ml, 100 ml bag
  • Inj 2 mg per ml, 200 ml bag
  • Inj 7.5 mg per ml, 10 ml ampoule
  • Inj 7.5 mg per ml, 20 ml ampoule
  • Inj 10 mg per ml, 10 ml ampoule
  • Inj 10 mg per ml, 20 ml ampoule

price increase and addition of PSS

SGLT2 Inhibitors

amended restriction criteria

Sildenafil (Sildenafil (Amarox)) tab 50 mg

new listing (p’code 2735962)

Tamsulosin hydrochloride (Aurobindo Tamsulosin) cap 400 mcg

new listing (p’code 2735865)

Temazepam (Normison) tab 10 mg

price increase and addition of PSS

Terbinafine (Deolate) tab 250 mg

price increase and addition of PSS

Teriparatide (Teriparatide Teva S29) inj 250 mcg per ml, 2.4 ml

new listing (p’code 2735768)

Ursodeoxycholic acid (Ursosan) cap 250 mg

price decrease and addition of PSS

Water inj 20 ml ampoule

Brand change

  • Multichem – new listing and
    addition of PSS (p’code 2208334)
  • Fresenius Kabi to be delisted 1 February 2027

Vitamin B complex (Bplex) tab strong, BPC

price increase

Zidovudine with lamivudine (Lamivudine/Zidovudine Viatris) tab 300 mg with lamivudine 150 mg

Pharmacode 2645300 to be delisted 1
February 2027